{"id":39,"date":"2025-02-10T08:01:19","date_gmt":"2025-02-10T08:01:19","guid":{"rendered":"https:\/\/repairgenes.org\/?p=39"},"modified":"2025-02-10T08:01:19","modified_gmt":"2025-02-10T08:01:19","slug":"mda-mb-157-cells-a-key-model-for-triple-negative-breast-cancer-research-and-therapeutic-innovations","status":"publish","type":"post","link":"https:\/\/repairgenes.org\/?p=39","title":{"rendered":"MDA-MB-157 Cells: A Key Model for Triple-Negative Breast Cancer Research and Therapeutic Innovations"},"content":{"rendered":"<h3 data-pm-slice=\"1 1 []\">Introduction to MDA-MB-157 Cells<\/h3>\n<p><strong>MDA-MB-157<\/strong> is a human breast cancer cell line that originates from a <strong>triple-negative breast cancer (TNBC)<\/strong> patient. These cells are widely used in <strong>cancer research<\/strong>, particularly in studies focused on <strong>tumor progression, metastasis, drug resistance, and therapeutic targets<\/strong>. Unlike hormone receptor-positive breast cancer cells, <strong>MDA-MB-157 lacks estrogen receptor (ER), progesterone receptor (PR), and HER2 expression<\/strong>, making it a challenging yet significant model for studying aggressive breast cancers.<\/p>\n<p>For more details on <strong>triple-negative breast cancer (TNBC)<\/strong>, visit the <strong>National Cancer Institute (NCI)<\/strong> (<a href=\"https:\/\/www.cancer.gov\/\">cancer.gov<\/a>) and <strong>Centers for Disease Control and Prevention (CDC)<\/strong> (<a href=\"https:\/\/www.cdc.gov\/\">cdc.gov<\/a>).<\/p>\n<h3><a href=\"https:\/\/www.afficell.com\/shop\/afg-ell-0070-afficell-r-human-breast-cancer-cells-mda-mb-157-306556\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-42 aligncenter\" src=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.26-A-3D-rendered-medical-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-being-targeted-by-novel-immunotherapy-treatments.-The-image-shoul-300x300.webp\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.26-A-3D-rendered-medical-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-being-targeted-by-novel-immunotherapy-treatments.-The-image-shoul-300x300.webp 300w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.26-A-3D-rendered-medical-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-being-targeted-by-novel-immunotherapy-treatments.-The-image-shoul-150x150.webp 150w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.26-A-3D-rendered-medical-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-being-targeted-by-novel-immunotherapy-treatments.-The-image-shoul-768x768.webp 768w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.26-A-3D-rendered-medical-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-being-targeted-by-novel-immunotherapy-treatments.-The-image-shoul.webp 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/h3>\n<h3><strong>Origin and Characteristics<\/strong><\/h3>\n<p>MDA-MB-157 cells were originally isolated from <strong>a 43-year-old female patient with breast adenocarcinoma<\/strong>. These cells exhibit <strong>high metastatic potential, mesenchymal-like morphology, and significant resistance to conventional therapies<\/strong>. Their aggressive behavior is relevant to studies on <strong>epithelial-mesenchymal transition (EMT), invasion, and tumor microenvironment interactions<\/strong>.<\/p>\n<p>For more information on the molecular characterization of <strong>MDA-MB-157<\/strong>, refer to the <strong>National Center for Biotechnology Information (NCBI)<\/strong> (<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/\">ncbi.nlm.nih.gov<\/a>).<\/p>\n<h3><strong>Applications in Cancer Research<\/strong><\/h3>\n<h4><strong>1. Tumor Progression and Metastasis<\/strong><\/h4>\n<p>MDA-MB-157 cells provide a <strong>valuable in vitro model<\/strong> for studying <strong>breast cancer invasion and metastasis<\/strong>. Their mesenchymal-like phenotype makes them useful for <strong>analyzing migration, extracellular matrix degradation, and cancer stem cell (CSC) properties<\/strong>.<\/p>\n<p>Research papers on <strong>breast cancer metastasis<\/strong> can be accessed via <strong>PubMed<\/strong> (<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/\">pubmed.ncbi.nlm.nih.gov<\/a>) and <strong>National Institutes of Health (NIH)<\/strong> (<a href=\"https:\/\/www.nih.gov\/\">nih.gov<\/a>).<\/p>\n<h4><strong>2. Drug Resistance Studies<\/strong><\/h4>\n<p>Triple-negative breast cancer is notorious for its <strong>lack of targeted therapies and high resistance to chemotherapy<\/strong>. Studies using MDA-MB-157 focus on <strong>multidrug resistance (MDR) mechanisms, apoptosis evasion, and novel therapeutic agents<\/strong>.<\/p>\n<p>For research on <strong>drug resistance in TNBC<\/strong>, visit <strong>ClinicalTrials.gov<\/strong> (<a href=\"https:\/\/clinicaltrials.gov\/\">clinicaltrials.gov<\/a>) and the <strong>U.S. Food and Drug Administration (FDA)<\/strong> (<a href=\"https:\/\/www.fda.gov\/\">fda.gov<\/a>).<\/p>\n<h4><a href=\"https:\/\/www.afficell.com\/shop\/afg-adx-061-afficell-r-mda-mb-157-cells-832782\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-40 aligncenter\" src=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.23-A-high-resolution-microscopic-image-of-MDA-MB-157-triple-negative-breast-cancer-cells.-The-cells-should-appear-irregularly-shaped-and-highly-invasive-300x300.webp\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.23-A-high-resolution-microscopic-image-of-MDA-MB-157-triple-negative-breast-cancer-cells.-The-cells-should-appear-irregularly-shaped-and-highly-invasive-300x300.webp 300w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.23-A-high-resolution-microscopic-image-of-MDA-MB-157-triple-negative-breast-cancer-cells.-The-cells-should-appear-irregularly-shaped-and-highly-invasive-150x150.webp 150w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.23-A-high-resolution-microscopic-image-of-MDA-MB-157-triple-negative-breast-cancer-cells.-The-cells-should-appear-irregularly-shaped-and-highly-invasive-768x768.webp 768w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.23-A-high-resolution-microscopic-image-of-MDA-MB-157-triple-negative-breast-cancer-cells.-The-cells-should-appear-irregularly-shaped-and-highly-invasive.webp 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/h4>\n<h4><strong>3. Immunotherapy and Targeted Therapies<\/strong><\/h4>\n<p>Since MDA-MB-157 lacks hormone receptors, researchers explore <strong>immune checkpoint inhibitors, monoclonal antibodies, and small molecule inhibitors<\/strong> as potential treatment strategies.<\/p>\n<p>For updates on <strong>cancer immunotherapy trials<\/strong>, refer to <strong>National Cancer Institute (NCI)<\/strong> (<a href=\"https:\/\/www.cancer.gov\/\">cancer.gov<\/a>) and <strong>Cancer Research UK<\/strong> (<a href=\"https:\/\/www.cancerresearchuk.org\/\">cancerresearchuk.org<\/a>).<\/p>\n<h4><strong>4. Gene Expression and Molecular Profiling<\/strong><\/h4>\n<p>MDA-MB-157 cells are commonly analyzed for <strong>gene expression profiling and transcriptomic studies<\/strong> to identify <strong>oncogenic pathways and novel biomarkers<\/strong>.<\/p>\n<p>For access to publicly available <strong>gene expression data<\/strong>, visit <strong>Genomic Data Commons (GDC)<\/strong> (<a>gdc.cancer.gov<\/a>) and <strong>The Cancer Genome Atlas (TCGA)<\/strong> (<a href=\"https:\/\/www.cancergenome.nih.gov\/\">cancergenome.nih.gov<\/a>).<\/p>\n<h4><strong>5. 3D Culture Models and Organoids<\/strong><\/h4>\n<p>Recent advances in <strong>three-dimensional (3D) culture techniques<\/strong> and <strong>tumor organoid models<\/strong> have significantly improved cancer research. MDA-MB-157 cells have been used to develop organoids that better simulate tumor biology, drug response, and microenvironment interactions.<\/p>\n<p>To learn more about <strong>3D culture technologies<\/strong>, visit <strong>Harvard Wyss Institute for Biologically Inspired Engineering<\/strong> (<a href=\"https:\/\/wyss.harvard.edu\/\">wyss.harvard.edu<\/a>) and <strong>National Cancer Institute&#8217;s Organoid Research<\/strong> (<a>cancer.gov<\/a>).<\/p>\n<h3><strong>Challenges and Limitations<\/strong><\/h3>\n<p>Despite its <strong>relevance in breast cancer research<\/strong>, the <strong>MDA-MB-157<\/strong> cell line has certain limitations:<\/p>\n<ul data-spread=\"false\">\n<li><strong>High heterogeneity:<\/strong> Exhibits genetic instability, making reproducibility difficult.<\/li>\n<li><strong>Low tumorigenicity in vivo:<\/strong> Unlike some other TNBC cell lines, MDA-MB-157 has relatively low tumor formation capacity in xenograft models.<\/li>\n<li><strong>Limited therapeutic response:<\/strong> Poor sensitivity to standard chemotherapeutics limits its application in <strong>drug screening assays<\/strong>.<\/li>\n<\/ul>\n<p>For a detailed review on <strong>breast cancer cell line models<\/strong>, explore research published by <strong>American Association for Cancer Research (AACR)<\/strong> (<a href=\"https:\/\/www.aacr.org\/\">aacr.org<\/a>) and <strong>National Comprehensive Cancer Network (NCCN)<\/strong> (<a href=\"https:\/\/www.nccn.org\/\">nccn.org<\/a>).<\/p>\n<h3><strong>Future Directions<\/strong><\/h3>\n<p>Ongoing research is aimed at improving the relevance of <strong>MDA-MB-157<\/strong> for <strong>personalized medicine<\/strong> by integrating:<\/p>\n<ul data-spread=\"false\">\n<li><strong>Organoid and 3D culture models<\/strong> for better mimicking tumor environments.<\/li>\n<li><strong>CRISPR-Cas9 gene editing<\/strong> to identify novel druggable targets.<\/li>\n<li><strong>Combination therapies<\/strong> to overcome chemoresistance.<\/li>\n<li><strong>Single-cell RNA sequencing<\/strong> for deeper molecular profiling.<\/li>\n<\/ul>\n<p>For insights into <strong>emerging breast cancer treatments<\/strong>, visit <strong>Stanford Medicine Cancer Center<\/strong> (<a href=\"https:\/\/med.stanford.edu\/\">med.stanford.edu<\/a>) and <strong>Harvard Medical School Cancer Research<\/strong> (<a href=\"https:\/\/hms.harvard.edu\/\">hms.harvard.edu<\/a>).<\/p>\n<h3><a href=\"https:\/\/www.afficell.com\/shop\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-41 aligncenter\" src=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.25-A-scientific-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-undergoing-metastasis.-The-image-should-depict-the-cells-spreading-from-a--300x300.webp\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.25-A-scientific-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-undergoing-metastasis.-The-image-should-depict-the-cells-spreading-from-a--300x300.webp 300w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.25-A-scientific-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-undergoing-metastasis.-The-image-should-depict-the-cells-spreading-from-a--150x150.webp 150w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.25-A-scientific-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-undergoing-metastasis.-The-image-should-depict-the-cells-spreading-from-a--768x768.webp 768w, https:\/\/repairgenes.org\/wp-content\/uploads\/2025\/02\/DALL\u00b7E-2025-02-10-08.59.25-A-scientific-illustration-of-MDA-MB-157-triple-negative-breast-cancer-cells-undergoing-metastasis.-The-image-should-depict-the-cells-spreading-from-a-.webp 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/h3>\n<h3><strong>Conclusion<\/strong><\/h3>\n<p>The <strong>MDA-MB-157<\/strong> cell line remains a valuable tool for <strong>understanding triple-negative breast cancer, drug resistance mechanisms, and novel therapeutic approaches<\/strong>. Despite its limitations, it continues to play a pivotal role in <strong>preclinical cancer research<\/strong>.<\/p>\n<p>For further reading, check resources from <strong>Mayo Clinic Cancer Center<\/strong> (<a href=\"https:\/\/www.mayoclinic.org\/\">mayoclinic.org<\/a>) and <strong>Memorial Sloan Kettering Cancer Center<\/strong> (<a href=\"https:\/\/www.mskcc.org\/\">mskcc.org<\/a>).<\/p>\n<p>As research progresses, novel strategies for targeting <strong>triple-negative breast cancer<\/strong> using <strong>MDA-MB-157<\/strong> will continue to emerge, offering hope for improved treatments and patient outcomes.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction to MDA-MB-157 Cells MDA-MB-157 is a human breast cancer cell line that originates from a triple-negative breast cancer (TNBC) patient. These cells are widely used in cancer research, particularly in studies focused on tumor progression, metastasis, drug resistance, and therapeutic targets. Unlike hormone receptor-positive breast cancer cells, MDA-MB-157 lacks estrogen receptor (ER), progesterone receptor [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-39","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/posts\/39","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/repairgenes.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39"}],"version-history":[{"count":1,"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/posts\/39\/revisions"}],"predecessor-version":[{"id":43,"href":"https:\/\/repairgenes.org\/index.php?rest_route=\/wp\/v2\/posts\/39\/revisions\/43"}],"wp:attachment":[{"href":"https:\/\/repairgenes.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/repairgenes.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/repairgenes.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}